找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Applied Statistics in Biomedicine and Clinical Trials Design; Selected Papers from Zhen Chen,Aiyi Liu,Yi Tsong Conference proceedings 2015

[复制链接]
楼主: 贬损
发表于 2025-3-26 21:35:56 | 显示全部楼层
Bayesian Functional Mixed Models for Survival Responses with Application to Prostate Cancerwhich not only allows dimension reduction of the parameter space but also allows efficient sampling from the conditional distributions. We illustrate our approach with a recent prostate cancer clinical trial study.
发表于 2025-3-27 05:00:29 | 显示全部楼层
Bayesian Predictive Approach to Early Termination for Enriched Enrollment Randomized Withdrawal Triabability for observing a sufficient magnitude of response rate at the end of enriched enrollment phase given the observed data at an interim look. The method is applied to derive futility stopping rules, and the sensitivity of the futility stopping rules is examined based upon the choice of prior di
发表于 2025-3-27 05:55:19 | 显示全部楼层
Group Sequential Methods for Comparing Correlated Receiver Operating Characteristic Curves and derive the asymptotic covariance structure for comparative ROC statistics. Relating the difference between empirical ROC curves to the Kiefer process, we also show these results can be used to conduct a GSD using standard software.
发表于 2025-3-27 11:01:18 | 显示全部楼层
Some Characteristics of the Varying-Stage Adaptive Phase II/III Clinical Trial Designrnative hypotheses for both plausible endpoints. Here, we explore characteristics of the design when the alternative hypothesis for only one of the two endpoints is true, and the treatment effect for another endpoint is null (an extremely worst case) or lower than what was anticipated per trial desi
发表于 2025-3-27 14:02:36 | 显示全部楼层
发表于 2025-3-27 19:30:15 | 显示全部楼层
发表于 2025-3-27 23:15:57 | 显示全部楼层
发表于 2025-3-28 05:49:34 | 显示全部楼层
发表于 2025-3-28 08:53:42 | 显示全部楼层
Bayesian Design of Noninferiority Clinical Trials with Co-primary Endpoints and Multiple Dose Comparpproach has the potential of power increase and hence sample size reduction due to the incorporation of the historical data and the correlation structure among multiple co-primary endpoints while it still maintains the family-wise type I error control without additional multiplicity adjustment. In t
发表于 2025-3-28 12:28:54 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-25 18:13
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表